Financial News
Latest News about MRNS
Recent news which mentions MRNS
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 08, 2022
From Benzinga
7 Sizzling Stocks That Are Oblivious to the Manic Market
October 20, 2022
From InvestorPlace
BARDA Exercises First Contract Option With Marinus Pharma For Its Epilepsy Candidate
September 22, 2022
Tickers
MRNS
From Benzinga
Looking Into Marinus Pharmaceuticals's Return On Capital Employed
September 06, 2022
Tickers
MRNS
From Benzinga
Earnings Scheduled For August 11, 2022
August 11, 2022
From Benzinga
From Benzinga
From Benzinga
74 Biggest Movers From Yesterday
June 03, 2022
From Benzinga
From Benzinga
From Benzinga
3 Biotech Stocks Under $10 to Add to Your Buy List
April 26, 2022
From InvestorPlace
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 21, 2022
From Benzinga
Earnings Scheduled For March 21, 2022
March 21, 2022
From Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
March 20, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 02, 2022
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Monday
February 28, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 25, 2022
From Benzinga
63 Biggest Movers From Yesterday
February 24, 2022
From Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
February 23, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 23, 2022
From Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
